And that solution is. . . to become a drug rep. A fake drug rep. And get access to all the free free brand name (no generics here) medications your heart desires. The story at Pharmalot states that a well dressed man:
“walked into a physician’s office in East Northport, New York, which is on Long Island, and helped himself to about $300 worth of drugs from a shelf after claiming he was a pharma sales rep.”
The man was apparently later caught. Perhaps he was sent to jail. I say send him to D.C., this may be the kind of creative thinking we need to reduce our health care costs!
See the full story here. And the follow up here.
This post at KevinMD has blown up and is generating significant interest.
Since writing it I was contacted by CNN, they talked about wanting to do a series on America’s addiction to medications and what sounded to me like the various excesses of drug companies to try to get people to take those medications. They wanted me to comment on the various excesses of Pharma from a physician’s perspective. They were interested in hearing about all the things the drug companies give us, specifically, free stuff, give-aways, trips, golf outings. . . you get the point. I explained that I had no experience with such things, nor did I know of anybody who had, and probably was not the right person to talk to.
I feel like in this discussion, we private practice physicians are guppies in a big ocean. The occasional office lunch amounts to essentially (excuse the pun) small potatoes compared to the influence that pharma has had on the opinion makers, and subsequently, in the drafting of practice guidelines (such as recent lipid guidelines or the use of activated protein C in sepsis). In this, the influence is insidious; it exists largely in rooms that are closed to the rest of us. The influence is not nearly as extroverted and obvious as CNN (and the rest of us) would like to see. However, I agree with many of you that having drug reps bringing lunch into the office at the very least gives the impression of influence, and may not be a practice that we as physicians can defend much longer. In retrospect, I wished I had agreed to the interview with CNN, only for the sweet irony of my interview being followed by a commercial featuring two elderly people sitting in bathtubs on top of a hill. . .
Oh Pfizer, Won’t You Buy Me a Mercedes-Benz?
Actually I’ll take a Ford Shelby GT500 Convertible, thank you. Today’s stream of random thinking comes to you after having feasted on a tasty lunch paid for by a drug company (and no, it wasn’t Pfizer). Continue reading “Drug Company Marketing”